AERIE PHARMACEUTICALS INC (AERI) Stock Analyst Earnings Estimates
NASDAQ:AERI - Nasdaq - US00771V1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 69.89M 189.04% | 83.14M 18.96% | 194.134M 133.50% | 140.26M -27.75% | 183.69M 30.96% | 231.52M 26.04% | 275.5M 19.00% | 304.95M 10.69% | |
| EBITDA YoY % growth | -182.35M 12.04% | -149.32M 18.11% | -39.955M 73.24% | -76.355M -91.10% | -26.553M 65.22% | 8.587M 132.34% | 2.825M -67.10% | 948.109K -66.44% | |
| EBIT YoY % growth | -187.49M 10.61% | -155.69M 16.96% | -46.354M 70.23% | -83.293M -79.69% | -44.865M 46.14% | 153.683K 100.34% | 40.836K -73.43% | 11.068K -72.90% | |
| Operating Margin | -268.26% | -187.26% | -23.88% | -59.38% | -24.42% | 0.07% | 0.01% | 0.00% | |
| EPS YoY % growth | -3.40 26.41% | -3.10 8.82% | -1.02 67.10% | -1.89 -85.63% | -1.03 45.60% | -0.06 94.06% | -0.10 -66.50% | -0.17 -69.83% |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.44 -140.25% | -0.33 50.55% | -0.29 10.75% | -0.20 24.44% | -0.10 76.75% |
| Revenue Q2Q % growth | 39.129M -65.88% | 39.678M 32.99% | 42.738M 28.30% | 47.736M 32.13% | 55.123M 40.88% |
| EBITDA Q2Q % growth | -16.472M -128.33% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.121M -135.02% | -13.389M 60.20% | -11.839M 34.72% | -7.87M 70.49% | -2.657M 85.34% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.27 62.50% | -0.45 | 0.18 | 39.47% |
| Q2 2022 Q2Q % growth | -0.32 52.24% | -0.57 | 0.25 | 44.16% |
| Q1 2022 Q2Q % growth | -0.66 8.33% | -0.67 | 0.01 | 0.99% |
| Q4 2021 Q2Q % growth | 1.09 237.97% | -0.69 | 1.78 | 258.61% |
| Q3 2021 Q2Q % growth | -0.72 -10.77% | -0.63 | -0.09 | -13.39% |
| Q2 2021 Q2Q % growth | -0.67 19.28% | -0.66 | -0.01 | -1.84% |
| Q1 2021 Q2Q % growth | -0.72 13.25% | -0.69 | -0.03 | -4.11% |
| Q4 2020 Q2Q % growth | -0.79 17.71% | -0.75 | -0.04 | -5.52% |
| Q3 2020 Q2Q % growth | -0.65 24.42% | -0.82 | 0.17 | 20.44% |
| Q2 2020 Q2Q % growth | -0.83 -3.75% | -0.81 | -0.02 | -2.28% |
| Q1 2020 Q2Q % growth | -0.83 -6.41% | -0.79 | -0.04 | -5.00% |
| Q4 2019 Q2Q % growth | -0.96 | -0.78 | -0.18 | -22.39% |
| Q3 2019 Q2Q % growth | -0.86 | -0.81 | -0.05 | -5.60% |
| Q2 2019 Q2Q % growth | -0.80 | -0.88 | 0.08 | 9.04% |
| Q1 2019 Q2Q % growth | -0.78 | -0.95 | 0.17 | 17.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 36.129M 23.25% | 36.195M | -66K | -0.18% |
| Q2 2022 Q2Q % growth | 33.311M 22.53% | 33.106M | 205K | 0.62% |
| Q1 2022 Q2Q % growth | 29.835M 29.89% | 30.466M | -631K | -2.07% |
| Q4 2021 Q2Q % growth | 114.666M 364.61% | 32.083M | 82.583M | 257.40% |
| Q3 2021 Q2Q % growth | 29.313M 45.98% | 29.473M | -160K | -0.54% |
| Q2 2021 Q2Q % growth | 27.185M 50.78% | 26.653M | 532K | 2.00% |
| Q1 2021 Q2Q % growth | 22.97M 12.93% | 23.121M | -151K | -0.65% |
| Q4 2020 Q2Q % growth | 24.68M 0.08% | 22.809M | 1.871M | 8.20% |
| Q3 2020 Q2Q % growth | 20.08M 8.31% | 20.102M | -22K | -0.11% |
| Q2 2020 Q2Q % growth | 18.03M 13.83% | 17.801M | 229K | 1.29% |
| Q1 2020 Q2Q % growth | 20.34M 87.47% | 20.458M | -118K | -0.58% |
| Q4 2019 Q2Q % growth | 24.66M | 19.851M | 4.809M | 24.23% |
| Q3 2019 Q2Q % growth | 18.54M | 18.092M | 448K | 2.48% |
| Q2 2019 Q2Q % growth | 15.84M | 16.187M | -347K | -2.14% |
| Q1 2019 Q2Q % growth | 10.85M | 13.724M | -2.874M | -20.94% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |